Amyloid fibril formation by a synthetic peptide from a region of human acetylcholinesterase that is homologous to the Alzheimer's amyloid-beta peptide - PubMed
- ️Tue Jan 01 2002
Comparative Study
. 2002 Nov 19;41(46):13539-47.
doi: 10.1021/bi0260334.
Affiliations
- PMID: 12427014
- DOI: 10.1021/bi0260334
Comparative Study
Amyloid fibril formation by a synthetic peptide from a region of human acetylcholinesterase that is homologous to the Alzheimer's amyloid-beta peptide
Matthew G Cottingham et al. Biochemistry. 2002.
Abstract
A region near the C-terminus of human acetylcholinesterase (AChE) is weakly homologous with the N-terminus of the Alzheimer's disease amyloid-beta peptide. We report that a 14-amino acid synthetic polypeptide whose sequence corresponds to residues 586-599 of the human synaptic or T form of AChE assembles into amyloid fibrils under physiological conditions. The fibrils have all the classical characteristics of amyloid: they have a diameter of 6-7 nm and bind both Congo red and thioflavin-T. Furthermore, the kinetics of assembly indicate that fibril formation proceeds via a two-step nucleation-dependent polymerization pathway, and a transition in the peptide conformation from random coil to beta-sheet is observed during fibril formation using far-UV circular dichroism spectroscopy. We also show that the peptide in aggregated fibrillar form has a toxic effect upon PC-12 cells in vitro. AChE normally resides mainly on cholinergic neuronal membranes, but is abnormally localized to senile plaques in Alzheimer's disease. Recently, an in vitro interaction between AChE and A beta, the principal constituent of the amyloid fibrils in senile plaques, has been documented. The presence of a fibrillogenic region within AChE may be relevant to the interaction of AChE with amyloid fibrils formed by Abeta.
Similar articles
-
Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E.
Castano EM, Prelli F, Wisniewski T, Golabek A, Kumar RA, Soto C, Frangione B. Castano EM, et al. Biochem J. 1995 Mar 1;306 ( Pt 2)(Pt 2):599-604. doi: 10.1042/bj3060599. Biochem J. 1995. PMID: 7534068 Free PMC article.
-
Alzheimer's beta-amyloid: insights into fibril formation and structure from Congo red binding.
Inouye H, Kirschner DA. Inouye H, et al. Subcell Biochem. 2005;38:203-24. doi: 10.1007/0-387-23226-5_10. Subcell Biochem. 2005. PMID: 15709480 Review.
-
Inestrosa NC, Alvarez A, Dinamarca MC, Pérez-Acle T, Colombres M. Inestrosa NC, et al. Curr Alzheimer Res. 2005 Jul;2(3):301-6. doi: 10.2174/1567205054367928. Curr Alzheimer Res. 2005. PMID: 15974895 Review.
Cited by
-
A mechanistic model for amorphous protein aggregation of immunoglobulin-like domains.
Borgia MB, Nickson AA, Clarke J, Hounslow MJ. Borgia MB, et al. J Am Chem Soc. 2013 May 1;135(17):6456-64. doi: 10.1021/ja308852b. Epub 2013 Apr 18. J Am Chem Soc. 2013. PMID: 23510407 Free PMC article.
-
Alzheimer's disease and type 2 diabetes mellitus: the cholinesterase connection?
Sridhar GR, Thota H, Allam AR, Suresh Babu C, Siva Prasad A, Divakar Ch. Sridhar GR, et al. Lipids Health Dis. 2006 Nov 11;5:28. doi: 10.1186/1476-511X-5-28. Lipids Health Dis. 2006. PMID: 17096857 Free PMC article.
-
Lopes JPB, Silva L, Lüdtke DS. Lopes JPB, et al. RSC Med Chem. 2021 Sep 8;12(12):2001-2015. doi: 10.1039/d1md00217a. eCollection 2021 Dec 15. RSC Med Chem. 2021. PMID: 35028560 Free PMC article. Review.
-
Conformational preferences of a 14-residue fibrillogenic peptide from acetylcholinesterase.
Vijayan R, Biggin PC. Vijayan R, et al. Biochemistry. 2010 May 4;49(17):3678-84. doi: 10.1021/bi1001807. Biochemistry. 2010. PMID: 20356043 Free PMC article.
-
Detecting hidden sequence propensity for amyloid fibril formation.
Yoon S, Welsh WJ. Yoon S, et al. Protein Sci. 2004 Aug;13(8):2149-60. doi: 10.1110/ps.04790604. Protein Sci. 2004. PMID: 15273309 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical